• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病血浆标志物水平对健康个体多层中心性的影响。

Effects of Alzheimer's disease plasma marker levels on multilayer centrality in healthy individuals.

作者信息

García-Colomo Alejandra, López-Sanz David, Taguas Ignacio, Carrasco-Gómez Martín, Spuch Carlos, Comis-Tuche María, Maestú Fernando

机构信息

Center for Cognitive and Computational Neuroscience, Complutense University of Madrid, Pozuelo de Alarcón, 28223, Spain.

Department of Experimental Psychology, Cognitive Psychology and Speech & Language Therapy, Complutense University of Madrid, Pozuelo de Alarcón, 28223, Spain.

出版信息

Alzheimers Res Ther. 2025 Jan 6;17(1):8. doi: 10.1186/s13195-024-01654-x.

DOI:10.1186/s13195-024-01654-x
PMID:39762903
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11702184/
Abstract

BACKGROUND

Changes in amyloid beta (Aβ) and phosphorylated tau brain levels are known to affect brain network organization but very little is known about how plasma markers can relate to these measures. We aimed to address the relationship between centrality network changes and two plasma pathology markers: phosphorylated tau at threonine 231 (p-tau231), a proxy for early Aβ change, and neurofilament light chain (Nfl), a marker of axonal degeneration.

METHODS

One hundred and four cognitively unimpaired individuals were divided into a high pathology load (33 individuals; HP) group and a low pathology (71 individuals; LP) one. All participants underwent a magnetoencephalography (MEG) recording, a neuropsychological evaluation and plasma sampling. With the MEG recordings, a compound centrality score for each brain source was calculated that considered both intra- and inter-band links. For each group, the relationship between this centrality score and the two plasma markers was studied by means of correlation analyses. Furthermore, the relationship between the centrality score and the plasma markers among the HP and LP groups was compared. Lastly, we investigated whether hubs were more intensely affected by these changes.

RESULTS

Increasing concentrations of p-tau231, which is a proxy of Aβ pathology, were associated with greater theta centrality score of posterior areas that increased their connectedness in the theta range with the remaining areas, regardless of the latter's frequency range. The opposite relationship was found for left areas that decreased their centrality score in the gamma frequency range. These results only emerged for HP individuals, who showed a significantly different relationship between centrality and p-tau231 compared to LP individuals. Hubs' centrality score in the theta band was significantly more affected by p-tau231 levels compared to less central regions.

CONCLUSIONS

Early brain network reorganizations in cognitively unimpaired individuals are associated with elevated plasma p-tau231, a proxy for very early Aβ changes, only among individuals who show signs of a higher pathology load. Posterior centrality score increases in the theta band are congruent with previous literature and theoretical models, while gamma centrality score losses could be associated with inhibitory neuron dysfunction. Hubs were more intensely affected by p-tau231, and changed to a higher degree, thus corroborating hubs' vulnerability.

摘要

背景

已知淀粉样蛋白β(Aβ)和磷酸化tau蛋白的脑内水平变化会影响脑网络组织,但对于血浆标志物如何与这些指标相关却知之甚少。我们旨在探讨中心性网络变化与两种血浆病理标志物之间的关系:苏氨酸231位点的磷酸化tau蛋白(p-tau231),它可作为早期Aβ变化的替代指标;以及神经丝轻链(Nfl),一种轴突退变的标志物。

方法

104名认知功能未受损的个体被分为高病理负荷组(33人;HP)和低病理组(71人;LP)。所有参与者均接受了脑磁图(MEG)记录、神经心理学评估和血浆采样。利用MEG记录,计算每个脑源的复合中心性得分,该得分同时考虑了带内和带间连接。对于每组,通过相关性分析研究该中心性得分与两种血浆标志物之间的关系。此外,比较了HP组和LP组中中心性得分与血浆标志物之间的关系。最后,我们研究了枢纽是否受这些变化的影响更为强烈。

结果

p-tau231浓度升高,作为Aβ病理的替代指标,与后部区域更大的θ波中心性得分相关,后部区域在θ波范围内与其余区域的连接性增加,而不论其余区域的频率范围如何。在γ频率范围内,左侧区域的中心性得分降低,呈现相反的关系。这些结果仅在HP个体中出现,与LP个体相比,HP个体在中心性与p-tau231之间表现出显著不同的关系。与中心性较低的区域相比,枢纽在θ波段的中心性得分受p-tau231水平的影响明显更大。

结论

在认知功能未受损的个体中,早期脑网络重组仅在显示出较高病理负荷迹象的个体中,与血浆p-tau231升高相关,p-tau231是非常早期Aβ变化的替代指标。θ波段后部中心性得分增加与先前的文献和理论模型一致,而γ波段中心性得分降低可能与抑制性神经元功能障碍有关。枢纽受p-tau231的影响更为强烈,且变化程度更高,从而证实了枢纽的易损性。

相似文献

1
Effects of Alzheimer's disease plasma marker levels on multilayer centrality in healthy individuals.阿尔茨海默病血浆标志物水平对健康个体多层中心性的影响。
Alzheimers Res Ther. 2025 Jan 6;17(1):8. doi: 10.1186/s13195-024-01654-x.
2
Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.血浆神经丝轻链与阿尔茨海默病影像学生物标志物的阶段特异性关联。
Brain. 2020 Dec 1;143(12):3793-3804. doi: 10.1093/brain/awaa342.
3
Sex differences in the relationships between 24-h rest-activity patterns and plasma markers of Alzheimer's disease pathology.24小时休息-活动模式与阿尔茨海默病病理血浆标志物之间关系的性别差异。
Alzheimers Res Ther. 2024 Dec 30;16(1):277. doi: 10.1186/s13195-024-01653-y.
4
Alzheimer's and neurodegenerative disease biomarkers in blood predict brain atrophy and cognitive decline.血液中的阿尔茨海默病和神经退行性疾病生物标志物可预测脑萎缩和认知能力下降。
Alzheimers Res Ther. 2024 Apr 30;16(1):94. doi: 10.1186/s13195-024-01459-y.
5
Plasma p-tau231: a new biomarker for incipient Alzheimer's disease pathology.血浆 p-tau231:早期阿尔茨海默病病理学的新生物标志物。
Acta Neuropathol. 2021 May;141(5):709-724. doi: 10.1007/s00401-021-02275-6. Epub 2021 Feb 14.
6
The impact of kidney function on Alzheimer's disease blood biomarkers: implications for predicting amyloid-β positivity.肾功能对阿尔茨海默病血液生物标志物的影响:对预测淀粉样蛋白-β阳性的意义。
Alzheimers Res Ther. 2025 Feb 19;17(1):48. doi: 10.1186/s13195-025-01692-z.
7
Minimum spanning tree analysis of unimpaired individuals at risk of Alzheimer's disease.对有患阿尔茨海默病风险的未受损个体进行最小生成树分析。
Brain Commun. 2024 Aug 20;6(5):fcae283. doi: 10.1093/braincomms/fcae283. eCollection 2024.
8
Associations of longitudinal plasma p-tau181 and NfL with tau-PET, Aβ-PET and cognition.纵向血浆 p-tau181 和 NfL 与 tau-PET、Aβ-PET 和认知的关联。
J Neurol Neurosurg Psychiatry. 2021 Dec;92(12):1289-1295. doi: 10.1136/jnnp-2020-325537. Epub 2021 Jun 29.
9
Blood biomarkers of neurodegeneration associate differently with amyloid deposition, medial temporal atrophy, and cerebrovascular changes in APOE ε4-enriched cognitively unimpaired elderly.载脂蛋白 E ε4 丰富的认知正常老年人的神经退行性血生物标志物与淀粉样蛋白沉积、内侧颞叶萎缩和脑血管变化的相关性不同。
Alzheimers Res Ther. 2024 May 18;16(1):112. doi: 10.1186/s13195-024-01477-w.
10
Elevated plasma neurofilament light was associated with multi-modal neuroimaging features in Alzheimer's disease signature regions and predicted future tau deposition.血浆神经丝轻链升高与阿尔茨海默病特征区域的多模态神经影像学特征相关,并可预测未来的tau 沉积。
BMC Neurol. 2024 Jul 6;24(1):236. doi: 10.1186/s12883-024-03728-7.

引用本文的文献

1
Dynamic functional connectivity is modulated by the amount of p-Tau231 in blood in cognitively intact participants.在认知功能正常的参与者中,动态功能连接性受血液中p-Tau231含量的调节。
bioRxiv. 2024 Jun 1:2024.05.29.596323. doi: 10.1101/2024.05.29.596323.

本文引用的文献

1
Toward a more comprehensive understanding of network centrality disruption in amnestic mild cognitive impairment: a MEG multilayer approach.为了更全面地理解遗忘型轻度认知障碍中网络中心性破坏:一项 MEG 多层方法。
Alzheimers Res Ther. 2024 Oct 9;16(1):216. doi: 10.1186/s13195-024-01576-8.
2
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup.修订的阿尔茨海默病诊断和分期标准:阿尔茨海默病协会工作组。
Alzheimers Dement. 2024 Aug;20(8):5143-5169. doi: 10.1002/alz.13859. Epub 2024 Jun 27.
3
Neurophysiological trajectories in Alzheimer's disease progression.
阿尔茨海默病进展中的神经生理轨迹。
Elife. 2024 Mar 28;12:RP91044. doi: 10.7554/eLife.91044.
4
Alterations of resting-state Gamma frequency characteristics in aging and Alzheimer's disease.衰老和阿尔茨海默病中静息态伽马频率特征的改变。
Cogn Neurodyn. 2023 Aug;17(4):829-844. doi: 10.1007/s11571-022-09873-4. Epub 2022 Sep 30.
5
Eigenvector centrality dynamics are related to Alzheimer's disease pathological changes in non-demented individuals.特征向量中心性动态与非痴呆个体的阿尔茨海默病病理变化相关。
Brain Commun. 2023 Mar 28;5(3):fcad088. doi: 10.1093/braincomms/fcad088. eCollection 2023.
6
2023 Alzheimer's disease facts and figures.2023 年阿尔茨海默病事实和数据。
Alzheimers Dement. 2023 Apr;19(4):1598-1695. doi: 10.1002/alz.13016. Epub 2023 Mar 14.
7
Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer's disease.血浆 p-tau231 和 p-tau217 作为临床前阿尔茨海默病淀粉样β病理的状态标志物。
Nat Med. 2022 Sep;28(9):1797-1801. doi: 10.1038/s41591-022-01925-w. Epub 2022 Aug 11.
8
Gamma band functional connectivity reduction in patients with amnestic mild cognitive impairment and epileptiform activity.遗忘型轻度认知障碍患者的γ波段功能连接性降低与癫痫样活动
Brain Commun. 2022 Feb 3;4(2):fcac012. doi: 10.1093/braincomms/fcac012. eCollection 2022.
9
Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease.脑脊液 p-tau231 作为阿尔茨海默病早期发病机制的生物标志物。
EBioMedicine. 2022 Feb;76:103836. doi: 10.1016/j.ebiom.2022.103836. Epub 2022 Feb 12.
10
Comparing tau status determined via plasma pTau181, pTau231 and [F]MK6240 tau-PET.比较通过血浆 pTau181、pTau231 和 [F]MK6240 tau-PET 检测到的 tau 状态。
EBioMedicine. 2022 Feb;76:103837. doi: 10.1016/j.ebiom.2022.103837. Epub 2022 Feb 6.